2013
DOI: 10.1007/s12257-012-0451-1
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of growth plate injury with microencapsulated chondrocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 23 publications
0
6
0
Order By: Relevance
“…In addition, they observed similar effects when the chondrocytes were either implanted immediately after the growth plate injury, or implanted following surgical removal of an existing bone bridge formed following a growth plate injury induced earlier (Lee et al 1998). More recently, Jin et al (2006) and Li et al (2013) also in a rabbit growth plate injury model reported success in restoring the growth plate to its original form, preventing bone bridge formation and in possibly preventing early ossification and closure of the growth plate following transplantation of chondrocytes (Jin et al 2006) or chondrocytes that were microencapsulated ) using a semipermeable membrane shown to be able to reduce potential transplantationassociated immunological reactions (Koo et al 2008, Revell & Athanasiou 2009.…”
Section: Chondrocyte Transplantation and The Regeneration Of Injured mentioning
confidence: 99%
“…In addition, they observed similar effects when the chondrocytes were either implanted immediately after the growth plate injury, or implanted following surgical removal of an existing bone bridge formed following a growth plate injury induced earlier (Lee et al 1998). More recently, Jin et al (2006) and Li et al (2013) also in a rabbit growth plate injury model reported success in restoring the growth plate to its original form, preventing bone bridge formation and in possibly preventing early ossification and closure of the growth plate following transplantation of chondrocytes (Jin et al 2006) or chondrocytes that were microencapsulated ) using a semipermeable membrane shown to be able to reduce potential transplantationassociated immunological reactions (Koo et al 2008, Revell & Athanasiou 2009.…”
Section: Chondrocyte Transplantation and The Regeneration Of Injured mentioning
confidence: 99%
“…From this standpoint, allogeneic chondrocytes may represent a better alternative if they present good results in future studies. Li et al (2013) used allogeneic chondrocytes harvested from distal femoral GPs, microencapsulated by semipermeable membranes, and transplant the preparations in a GP injury model. Sixteen weeks later, the chondrocytes-treated group showed less length discrepancy and angular deformity than other groups, the histological results also exhibited columnar arrangement formed by neogenetic chondrocytes at the injured site, which indicated that the allogeneic chondrocytes could prevent bone formation to the same extent as autologous chondrocytes.…”
Section: Cartilage Tissue Engineering For Gp Injuriesmentioning
confidence: 99%
“…In a GP injuries model, alginate-polylysinealginate semipermeable membranes were used for chondrocyte encapsulation. After 16 weeks of implantation into defects, the radiological results showed less angular deformity and length discrepancies, indicating this alginate material was suitable for GP reconstruction ( Li et al, 2013 ). However, alginate hydrogel is negatively charged, which results in a dissimilar environment for encapsulated cells ( Freeman and Kelly, 2017 ).…”
Section: Cartilage Tissue Engineering For Gp Injuriesmentioning
confidence: 99%
“…Microencapsulated somatic cells can be used to treat neurological and endocrine diseases, such as diabetes, syndromes after the removal of ovaries, and Parkinson's disease . Microencapsulated stem cells can aid bone regeneration and growth plate injury, repair the myocardium and improve angiogenesis . Microencapsulated recombinant cells can be used to enhance memory in Alzheimer's disease and increase IDUA activity in mucopolysaccharidosis type I .…”
Section: Introductionmentioning
confidence: 99%